Baird Financial Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Buy |
30,700
+20,000
| +187% | +$177K | ﹤0.01% | 1619 |
|
|
2025
Q1 | $83.8K | Hold |
10,700
| – | – | ﹤0.01% | 1728 |
|
|
2024
Q4 | $112K | Hold |
10,700
| – | – | ﹤0.01% | 1713 |
|
|
2024
Q3 | $140K | Hold |
10,700
| – | – | ﹤0.01% | 1681 |
|
|
2024
Q2 | $150K | Buy |
10,700
+700
| +7% | +$9.84K | ﹤0.01% | 1701 |
|
|
2024
Q1 | $169K | Hold |
10,000
| – | – | ﹤0.01% | 1691 |
|
|
2023
Q4 | $141K | Buy |
+10,000
| New | +$141K | ﹤0.01% | 1663 |
|